Listed

Sensus Healthcare, Inc.

SRTSNasdaqCIK 1494891HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$2.3m, Q2 FY2026
Operating income−$3.2m, Q2 FY2026
Net income−$8.7m, Q2 FY2026
Sensus Healthcare, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m3.9Revenue, Q3 FY2023, three months to 2023-09-30$3.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2024-11-14, accession 0001213900-24-098193.Report this figure12.6Revenue, Q4 FY2023, three months to 2023-12-31$12.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-05, accession 0001753926-25-000408. Derived: 12-month figure less the 9-month figure.Report this figure10.7Revenue, Q1 FY2024, three months to 2024-03-31$10.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-15, accession 0001753926-25-000853.Report this figure9.2Revenue, Q2 FY2024, three months to 2024-06-30$9.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-12, accession 0001753926-25-001290.Report this figure8.8Revenue, Q3 FY2024, three months to 2024-09-30$8.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-12, accession 0001753926-25-001745.Report this figure13.1Revenue, Q4 FY2024, three months to 2024-12-31$13.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-04, accession 0001753926-26-000435. Derived: 12-month figure less the 9-month figure.Report this figure8.3Revenue, Q1 FY2025, three months to 2025-03-31$8.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-15, accession 0001753926-25-000853.Report this figure7.3Revenue, Q2 FY2025, three months to 2025-06-30$7.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-12, accession 0001753926-25-001290.Report this figure6.9Revenue, Q3 FY2025, three months to 2025-09-30$6.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-12, accession 0001753926-25-001745.Report this figure4.9Revenue, Q4 FY2025, three months to 2025-12-31$4.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-04, accession 0001753926-26-000435. Derived: 12-month figure less the 9-month figure.Report this figure3.4Revenue, Q1 FY2026, three months to 2026-03-31$3.4m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-13, accession 0001753926-26-000845.Report this figure2.3Revenue, Q2 FY2026, three months to 2026-06-30$2.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-14, accession 0001753926-26-001508.Report this figure
Cost of revenue$m1.9Cost of revenue, Q3 FY2023, three months to 2023-09-30$1.9m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2024-11-14, accession 0001213900-24-098193.Report this figure4.7Cost of revenue, Q4 FY2023, three months to 2023-12-31$4.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2025-03-05, accession 0001753926-25-000408. Derived: 12-month figure less the 9-month figure.Report this figure4.0Cost of revenue, Q1 FY2024, three months to 2024-03-31$4.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-15, accession 0001753926-25-000853.Report this figure3.8Cost of revenue, Q2 FY2024, three months to 2024-06-30$3.8m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2024-08-13, accession 0001213900-24-068165.Report this figure3.6Cost of revenue, Q3 FY2024, three months to 2024-09-30$3.6m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2024-11-14, accession 0001213900-24-098193.Report this figure6.0Cost of revenue, Q4 FY2024, three months to 2024-12-31$6.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-04, accession 0001753926-26-000435. Derived: 12-month figure less the 9-month figure.Report this figure4.0Cost of revenue, Q1 FY2025, three months to 2025-03-31$4.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-13, accession 0001753926-26-000845.Report this figure4.4Cost of revenue, Q2 FY2025, three months to 2025-06-30$4.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-14, accession 0001753926-26-001508.Report this figure4.2Cost of revenue, Q3 FY2025, three months to 2025-09-30$4.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-12, accession 0001753926-25-001745.Report this figure3.0Cost of revenue, Q4 FY2025, three months to 2025-12-31$3.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-04, accession 0001753926-26-000435. Derived: 12-month figure less the 9-month figure.Report this figure2.4Cost of revenue, Q1 FY2026, three months to 2026-03-31$2.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-13, accession 0001753926-26-000845.Report this figure1.5Cost of revenue, Q2 FY2026, three months to 2026-06-30$1.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-14, accession 0001753926-26-001508.Report this figure
Gross profit$m2.0Gross profit, Q3 FY2023, three months to 2023-09-30$2.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-14, accession 0001213900-24-098193.Report this figure7.8Gross profit, Q4 FY2023, three months to 2023-12-31$7.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-03-05, accession 0001753926-25-000408. Derived: 12-month figure less the 9-month figure.Report this figure6.7Gross profit, Q1 FY2024, three months to 2024-03-31$6.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-15, accession 0001753926-25-000853.Report this figure5.4Gross profit, Q2 FY2024, three months to 2024-06-30$5.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-12, accession 0001753926-25-001290.Report this figure5.2Gross profit, Q3 FY2024, three months to 2024-09-30$5.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-12, accession 0001753926-25-001745.Report this figure7.1Gross profit, Q4 FY2024, three months to 2024-12-31$7.1m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-04, accession 0001753926-26-000435. Derived: 12-month figure less the 9-month figure.Report this figure4.4Gross profit, Q1 FY2025, three months to 2025-03-31$4.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-13, accession 0001753926-26-000845.Report this figure2.9Gross profit, Q2 FY2025, three months to 2025-06-30$2.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-14, accession 0001753926-26-001508.Report this figure2.7Gross profit, Q3 FY2025, three months to 2025-09-30$2.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-12, accession 0001753926-25-001745.Report this figure1.9Gross profit, Q4 FY2025, three months to 2025-12-31$1.9m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-04, accession 0001753926-26-000435. Derived: 12-month figure less the 9-month figure.Report this figure1.0Gross profit, Q1 FY2026, three months to 2026-03-31$991.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-13, accession 0001753926-26-000845.Report this figure0.8Gross profit, Q2 FY2026, three months to 2026-06-30$769.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-14, accession 0001753926-26-001508.Report this figure
Research and development$m1.1Research and development, Q3 FY2023, three months to 2023-09-30$1.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-14, accession 0001213900-24-098193.Report this figure0.7Research and development, Q4 FY2023, three months to 2023-12-31$677.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-05, accession 0001753926-25-000408. Derived: 12-month figure less the 9-month figure.Report this figure0.9Research and development, Q1 FY2024, three months to 2024-03-31$926.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-15, accession 0001753926-25-000853.Report this figure0.9Research and development, Q2 FY2024, three months to 2024-06-30$866.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-12, accession 0001753926-25-001290.Report this figure0.9Research and development, Q3 FY2024, three months to 2024-09-30$863.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001753926-25-001745.Report this figure1.6Research and development, Q4 FY2024, three months to 2024-12-31$1.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-04, accession 0001753926-26-000435. Derived: 12-month figure less the 9-month figure.Report this figure2.6Research and development, Q1 FY2025, three months to 2025-03-31$2.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001753926-26-000845.Report this figure1.5Research and development, Q2 FY2025, three months to 2025-06-30$1.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-14, accession 0001753926-26-001508.Report this figure1.8Research and development, Q3 FY2025, three months to 2025-09-30$1.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001753926-25-001745.Report this figure1.9Research and development, Q4 FY2025, three months to 2025-12-31$1.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-04, accession 0001753926-26-000435. Derived: 12-month figure less the 9-month figure.Report this figure1.6Research and development, Q1 FY2026, three months to 2026-03-31$1.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001753926-26-000845.Report this figure1.1Research and development, Q2 FY2026, three months to 2026-06-30$1.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-14, accession 0001753926-26-001508.Report this figure
Selling, general and administrative$mnot reportednot reported1.6Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$1.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-15, accession 0001753926-25-000853.Report this figure1.6Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$1.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-12, accession 0001753926-25-001290.Report this figure1.6Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$1.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-12, accession 0001753926-25-001745.Report this figure2.4Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$2.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-04, accession 0001753926-26-000435. Derived: 12-month figure less the 9-month figure.Report this figure2.2Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$2.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-13, accession 0001753926-26-000845.Report this figure2.0Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$2.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-14, accession 0001753926-26-001508.Report this figure1.9Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$1.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-12, accession 0001753926-25-001745.Report this figure1.8Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$1.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-04, accession 0001753926-26-000435. Derived: 12-month figure less the 9-month figure.Report this figure2.0Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$2.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-13, accession 0001753926-26-000845.Report this figure1.8Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$1.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-14, accession 0001753926-26-001508.Report this figure
Operating income$m(1.9)Operating income, Q3 FY2023, three months to 2023-09-30−$1.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-14, accession 0001213900-24-098193.Report this figure5.6Operating income, Q4 FY2023, three months to 2023-12-31$5.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-05, accession 0001753926-25-000408. Derived: 12-month figure less the 9-month figure.Report this figure2.9Operating income, Q1 FY2024, three months to 2024-03-31$2.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-15, accession 0001753926-25-000853.Report this figure2.0Operating income, Q2 FY2024, three months to 2024-06-30$2.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-12, accession 0001753926-25-001290.Report this figure1.5Operating income, Q3 FY2024, three months to 2024-09-30$1.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001753926-25-001745.Report this figure1.7Operating income, Q4 FY2024, three months to 2024-12-31$1.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-04, accession 0001753926-26-000435. Derived: 12-month figure less the 9-month figure.Report this figure(2.6)Operating income, Q1 FY2025, three months to 2025-03-31−$2.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001753926-26-000845.Report this figure(1.9)Operating income, Q2 FY2025, three months to 2025-06-30−$1.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001753926-26-001508.Report this figure(2.6)Operating income, Q3 FY2025, three months to 2025-09-30−$2.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001753926-25-001745.Report this figure(3.1)Operating income, Q4 FY2025, three months to 2025-12-31−$3.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-04, accession 0001753926-26-000435. Derived: 12-month figure less the 9-month figure.Report this figure(4.4)Operating income, Q1 FY2026, three months to 2026-03-31−$4.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001753926-26-000845.Report this figure(3.2)Operating income, Q2 FY2026, three months to 2026-06-30−$3.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001753926-26-001508.Report this figure
Interest expense$mnot reportednot reported(0.2)Interest expense, Q1 FY2024, three months to 2024-03-31−$214.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-05-15, accession 0001753926-25-000853.Report this figure(0.2)Interest expense, Q2 FY2024, three months to 2024-06-30−$209.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-08-12, accession 0001753926-25-001290.Report this figurenot reportednot reported(0.2)Interest expense, Q1 FY2025, three months to 2025-03-31−$184.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-05-15, accession 0001753926-25-000853.Report this figure(0.2)Interest expense, Q2 FY2025, three months to 2025-06-30−$183.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-08-12, accession 0001753926-25-001290.Report this figurenot reportednot reportednot reportednot reported
Income tax$m(0.1)Income tax, Q3 FY2023, three months to 2023-09-30−$125.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-14, accession 0001213900-24-098193.Report this figure1.6Income tax, Q4 FY2023, three months to 2023-12-31$1.6m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-05, accession 0001753926-25-000408. Derived: 12-month figure less the 9-month figure.Report this figure0.8Income tax, Q1 FY2024, three months to 2024-03-31$827.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-15, accession 0001753926-25-000853.Report this figure0.6Income tax, Q2 FY2024, three months to 2024-06-30$579.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-12, accession 0001753926-25-001290.Report this figure0.6Income tax, Q3 FY2024, three months to 2024-09-30$559.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001753926-25-001745.Report this figure0.4Income tax, Q4 FY2024, three months to 2024-12-31$410.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-04, accession 0001753926-26-000435. Derived: 12-month figure less the 9-month figure.Report this figure0.1Income tax, Q1 FY2025, three months to 2025-03-31$110.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-13, accession 0001753926-26-000845.Report this figure(0.7)Income tax, Q2 FY2025, three months to 2025-06-30−$723.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-14, accession 0001753926-26-001508.Report this figure(1.5)Income tax, Q3 FY2025, three months to 2025-09-30−$1.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001753926-25-001745.Report this figure0.2Income tax, Q4 FY2025, three months to 2025-12-31$174.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-04, accession 0001753926-26-000435. Derived: 12-month figure less the 9-month figure.Report this figure(1.6)Income tax, Q1 FY2026, three months to 2026-03-31−$1.6m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-13, accession 0001753926-26-000845.Report this figure5.7Income tax, Q2 FY2026, three months to 2026-06-30$5.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-14, accession 0001753926-26-001508.Report this figure
Net income$m(1.5)Net income, Q3 FY2023, three months to 2023-09-30−$1.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-14, accession 0001213900-24-098193.Report this figure4.2Net income, Q4 FY2023, three months to 2023-12-31$4.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-05, accession 0001753926-25-000408. Derived: 12-month figure less the 9-month figure.Report this figure2.3Net income, Q1 FY2024, three months to 2024-03-31$2.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001753926-25-001745.Report this figure1.6Net income, Q2 FY2024, three months to 2024-06-30$1.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001753926-25-001745.Report this figure1.2Net income, Q3 FY2024, three months to 2024-09-30$1.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001753926-25-001745.Report this figure1.5Net income, Q4 FY2024, three months to 2024-12-31$1.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-04, accession 0001753926-26-000435. Derived: 12-month figure less the 9-month figure.Report this figure(2.6)Net income, Q1 FY2025, three months to 2025-03-31−$2.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001753926-26-001508.Report this figure(1.0)Net income, Q2 FY2025, three months to 2025-06-30−$1.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001753926-26-001508.Report this figure(0.9)Net income, Q3 FY2025, three months to 2025-09-30−$943.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001753926-25-001745.Report this figure(3.2)Net income, Q4 FY2025, three months to 2025-12-31−$3.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-04, accession 0001753926-26-000435. Derived: 12-month figure less the 9-month figure.Report this figure(2.6)Net income, Q1 FY2026, three months to 2026-03-31−$2.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001753926-26-001508.Report this figure(8.7)Net income, Q2 FY2026, three months to 2026-06-30−$8.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001753926-26-001508.Report this figure
Diluted EPS$ per share(0.09)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-14, accession 0001213900-24-098193.Report this figurenot reported0.14Diluted EPS, Q1 FY2024, three months to 2024-03-31$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-15, accession 0001753926-25-000853.Report this figure0.10Diluted EPS, Q2 FY2024, three months to 2024-06-30$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-12, accession 0001753926-25-001290.Report this figure0.07Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001753926-25-001745.Report this figurenot reported(0.16)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001753926-26-000845.Report this figure(0.06)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-14, accession 0001753926-26-001508.Report this figure(0.06)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001753926-25-001745.Report this figurenot reported(0.16)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001753926-26-000845.Report this figure(0.53)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.53 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-14, accession 0001753926-26-001508.Report this figure
Basic EPS$ per share(0.09)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-14, accession 0001213900-24-098193.Report this figurenot reported0.14Basic EPS, Q1 FY2024, three months to 2024-03-31$0.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-15, accession 0001753926-25-000853.Report this figure0.10Basic EPS, Q2 FY2024, three months to 2024-06-30$0.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-12, accession 0001753926-25-001290.Report this figure0.07Basic EPS, Q3 FY2024, three months to 2024-09-30$0.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001753926-25-001745.Report this figurenot reported(0.16)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001753926-26-000845.Report this figure(0.06)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-14, accession 0001753926-26-001508.Report this figure(0.06)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001753926-25-001745.Report this figurenot reported(0.16)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001753926-26-000845.Report this figure(0.53)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.53 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-14, accession 0001753926-26-001508.Report this figure

Balance sheet

Cash and equivalents$15.2m, Q2 FY2026
Shareholders' equity$36.9m, Q2 FY2026
Sensus Healthcare, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m20.5Cash and equivalents, Q3 FY2023, at 2023-09-30$20.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-13, accession 0001213900-23-086237.Report this figure23.1Cash and equivalents, FY2023, at 2023-12-31$23.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-05, accession 0001753926-25-000408.Report this figure14.7Cash and equivalents, Q1 FY2024, at 2024-03-31$14.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-10, accession 0001213900-24-041605.Report this figure19.0Cash and equivalents, Q2 FY2024, at 2024-06-30$19.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-13, accession 0001213900-24-068165.Report this figure22.6Cash and equivalents, Q3 FY2024, at 2024-09-30$22.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-14, accession 0001213900-24-098193.Report this figure22.1Cash and equivalents, FY2024, at 2024-12-31$22.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-04, accession 0001753926-26-000435.Report this figure19.1Cash and equivalents, Q1 FY2025, at 2025-03-31$19.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-15, accession 0001753926-25-000853.Report this figure22.2Cash and equivalents, Q2 FY2025, at 2025-06-30$22.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-12, accession 0001753926-25-001290.Report this figure24.5Cash and equivalents, Q3 FY2025, at 2025-09-30$24.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001753926-25-001745.Report this figure22.1Cash and equivalents, FY2025, at 2025-12-31$22.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-14, accession 0001753926-26-001508.Report this figure18.3Cash and equivalents, Q1 FY2026, at 2026-03-31$18.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-13, accession 0001753926-26-000845.Report this figure15.2Cash and equivalents, Q2 FY2026, at 2026-06-30$15.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-14, accession 0001753926-26-001508.Report this figure
Current assets$m45.9Current assets, Q3 FY2023, at 2023-09-30$45.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-13, accession 0001213900-23-086237.Report this figure49.5Current assets, FY2023, at 2023-12-31$49.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-05, accession 0001753926-25-000408.Report this figure53.9Current assets, Q1 FY2024, at 2024-03-31$53.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-10, accession 0001213900-24-041605.Report this figure54.5Current assets, Q2 FY2024, at 2024-06-30$54.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-13, accession 0001213900-24-068165.Report this figure54.8Current assets, Q3 FY2024, at 2024-09-30$54.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-14, accession 0001213900-24-098193.Report this figure56.7Current assets, FY2024, at 2024-12-31$56.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-04, accession 0001753926-26-000435.Report this figure54.2Current assets, Q1 FY2025, at 2025-03-31$54.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-15, accession 0001753926-25-000853.Report this figure52.2Current assets, Q2 FY2025, at 2025-06-30$52.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-12, accession 0001753926-25-001290.Report this figure50.2Current assets, Q3 FY2025, at 2025-09-30$50.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001753926-25-001745.Report this figure45.9Current assets, FY2025, at 2025-12-31$45.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-14, accession 0001753926-26-001508.Report this figure42.6Current assets, Q1 FY2026, at 2026-03-31$42.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-13, accession 0001753926-26-000845.Report this figure37.7Current assets, Q2 FY2026, at 2026-06-30$37.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-14, accession 0001753926-26-001508.Report this figure
Total assets$m50.5Total assets, Q3 FY2023, at 2023-09-30$50.5m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-13, accession 0001213900-23-086237.Report this figure53.7Total assets, FY2023, at 2023-12-31$53.7m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-05, accession 0001753926-25-000408.Report this figure57.3Total assets, Q1 FY2024, at 2024-03-31$57.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-10, accession 0001213900-24-041605.Report this figure58.2Total assets, Q2 FY2024, at 2024-06-30$58.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-13, accession 0001213900-24-068165.Report this figure59.9Total assets, Q3 FY2024, at 2024-09-30$59.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-14, accession 0001213900-24-098193.Report this figure62.2Total assets, FY2024, at 2024-12-31$62.2m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-04, accession 0001753926-26-000435.Report this figure60.2Total assets, Q1 FY2025, at 2025-03-31$60.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-15, accession 0001753926-25-000853.Report this figure58.9Total assets, Q2 FY2025, at 2025-06-30$58.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-12, accession 0001753926-25-001290.Report this figure58.3Total assets, Q3 FY2025, at 2025-09-30$58.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001753926-25-001745.Report this figure53.0Total assets, FY2025, at 2025-12-31$53.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-14, accession 0001753926-26-001508.Report this figure51.5Total assets, Q1 FY2026, at 2026-03-31$51.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-13, accession 0001753926-26-000845.Report this figure41.3Total assets, Q2 FY2026, at 2026-06-30$41.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-14, accession 0001753926-26-001508.Report this figure
Current liabilities$m5.2Current liabilities, Q3 FY2023, at 2023-09-30$5.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-13, accession 0001213900-23-086237.Report this figure4.2Current liabilities, FY2023, at 2023-12-31$4.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-05, accession 0001753926-25-000408.Report this figure5.5Current liabilities, Q1 FY2024, at 2024-03-31$5.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-10, accession 0001213900-24-041605.Report this figure4.7Current liabilities, Q2 FY2024, at 2024-06-30$4.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-13, accession 0001213900-24-068165.Report this figure5.2Current liabilities, Q3 FY2024, at 2024-09-30$5.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-14, accession 0001213900-24-098193.Report this figure5.9Current liabilities, FY2024, at 2024-12-31$5.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-04, accession 0001753926-26-000435.Report this figure6.7Current liabilities, Q1 FY2025, at 2025-03-31$6.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-15, accession 0001753926-25-000853.Report this figure6.4Current liabilities, Q2 FY2025, at 2025-06-30$6.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-12, accession 0001753926-25-001290.Report this figure6.8Current liabilities, Q3 FY2025, at 2025-09-30$6.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001753926-25-001745.Report this figure4.7Current liabilities, FY2025, at 2025-12-31$4.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-14, accession 0001753926-26-001508.Report this figure5.9Current liabilities, Q1 FY2026, at 2026-03-31$5.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-13, accession 0001753926-26-000845.Report this figure4.3Current liabilities, Q2 FY2026, at 2026-06-30$4.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-14, accession 0001753926-26-001508.Report this figure
Total liabilities$m6.0Total liabilities, Q3 FY2023, at 2023-09-30$6.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-13, accession 0001213900-23-086237.Report this figure4.9Total liabilities, FY2023, at 2023-12-31$4.9m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-05, accession 0001753926-25-000408.Report this figure6.1Total liabilities, Q1 FY2024, at 2024-03-31$6.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-10, accession 0001213900-24-041605.Report this figure5.3Total liabilities, Q2 FY2024, at 2024-06-30$5.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-13, accession 0001213900-24-068165.Report this figure5.7Total liabilities, Q3 FY2024, at 2024-09-30$5.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-14, accession 0001213900-24-098193.Report this figure6.3Total liabilities, FY2024, at 2024-12-31$6.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-04, accession 0001753926-26-000435.Report this figure7.2Total liabilities, Q1 FY2025, at 2025-03-31$7.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-15, accession 0001753926-25-000853.Report this figure6.8Total liabilities, Q2 FY2025, at 2025-06-30$6.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-12, accession 0001753926-25-001290.Report this figure7.1Total liabilities, Q3 FY2025, at 2025-09-30$7.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001753926-25-001745.Report this figure4.9Total liabilities, FY2025, at 2025-12-31$4.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-14, accession 0001753926-26-001508.Report this figure6.0Total liabilities, Q1 FY2026, at 2026-03-31$6.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-13, accession 0001753926-26-000845.Report this figure4.4Total liabilities, Q2 FY2026, at 2026-06-30$4.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-14, accession 0001753926-26-001508.Report this figure
Shareholders' equity$m44.6Shareholders' equity, Q3 FY2023, at 2023-09-30$44.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-14, accession 0001213900-24-098193.Report this figure48.8Shareholders' equity, FY2023, at 2023-12-31$48.8m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-04, accession 0001753926-26-000435.Report this figure51.2Shareholders' equity, Q1 FY2024, at 2024-03-31$51.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001753926-25-001745.Report this figure52.9Shareholders' equity, Q2 FY2024, at 2024-06-30$52.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001753926-25-001745.Report this figure54.1Shareholders' equity, Q3 FY2024, at 2024-09-30$54.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001753926-25-001745.Report this figure55.8Shareholders' equity, FY2024, at 2024-12-31$55.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001753926-26-001508.Report this figure53.0Shareholders' equity, Q1 FY2025, at 2025-03-31$53.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001753926-26-001508.Report this figure52.1Shareholders' equity, Q2 FY2025, at 2025-06-30$52.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001753926-26-001508.Report this figure51.2Shareholders' equity, Q3 FY2025, at 2025-09-30$51.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001753926-25-001745.Report this figure48.1Shareholders' equity, FY2025, at 2025-12-31$48.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001753926-26-001508.Report this figure45.5Shareholders' equity, Q1 FY2026, at 2026-03-31$45.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001753926-26-001508.Report this figure36.9Shareholders' equity, Q2 FY2026, at 2026-06-30$36.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001753926-26-001508.Report this figure

Cash flow

Operating cash flow−$3.1m, Q2 FY2026
Capital expenditure$8.0k, Q2 FY2026
Share repurchases$0, Q4 FY2025
Sensus Healthcare, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$k442Operating cash flow, Q3 FY2023, three months to 2023-09-30$442.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-14, accession 0001213900-24-098193. Derived: 9-month figure less the 6-month figure.Report this figure2,668Operating cash flow, Q4 FY2023, three months to 2023-12-31$2.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-05, accession 0001753926-25-000408. Derived: 12-month figure less the 9-month figure.Report this figure(8,187)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$8.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-15, accession 0001753926-25-000853.Report this figure4,230Operating cash flow, Q2 FY2024, three months to 2024-06-30$4.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-12, accession 0001753926-25-001290. Derived: 6-month figure less the 3-month figure.Report this figure3,953Operating cash flow, Q3 FY2024, three months to 2024-09-30$4.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001753926-25-001745. Derived: 9-month figure less the 6-month figure.Report this figure(827)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$827.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-04, accession 0001753926-26-000435. Derived: 12-month figure less the 9-month figure.Report this figure(2,677)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$2.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001753926-26-000845.Report this figure3,117Operating cash flow, Q2 FY2025, three months to 2025-06-30$3.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-14, accession 0001753926-26-001508. Derived: 6-month figure less the 3-month figure.Report this figure2,295Operating cash flow, Q3 FY2025, three months to 2025-09-30$2.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001753926-25-001745. Derived: 9-month figure less the 6-month figure.Report this figure(2,207)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$2.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-04, accession 0001753926-26-000435. Derived: 12-month figure less the 9-month figure.Report this figure(3,753)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$3.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001753926-26-000845.Report this figure(3,133)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$3.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-14, accession 0001753926-26-001508. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$k11.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$11.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-14, accession 0001213900-24-098193. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-05, accession 0001753926-25-000408. Derived: 12-month figure less the 9-month figure.Report this figure233Capital expenditure, Q1 FY2024, three months to 2024-03-31$233.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-15, accession 0001753926-25-000853.Report this figure3.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$3.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-12, accession 0001753926-25-001290. Derived: 6-month figure less the 3-month figure.Report this figure337Capital expenditure, Q3 FY2024, three months to 2024-09-30$337.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001753926-25-001745. Derived: 9-month figure less the 6-month figure.Report this figure(297)Capital expenditure, Q4 FY2024, three months to 2024-12-31−$297.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-04, accession 0001753926-26-000435. Derived: 12-month figure less the 9-month figure.Report this figure7.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$7.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001753926-26-000845.Report this figure27.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$27.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-14, accession 0001753926-26-001508. Derived: 6-month figure less the 3-month figure.Report this figure4.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$4.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001753926-25-001745. Derived: 9-month figure less the 6-month figure.Report this figure158Capital expenditure, Q4 FY2025, three months to 2025-12-31$158.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-04, accession 0001753926-26-000435. Derived: 12-month figure less the 9-month figure.Report this figure3.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$3.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001753926-26-000845.Report this figure8.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$8.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-14, accession 0001753926-26-001508. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$knot reported0.0Share repurchases, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2025-03-05, accession 0001753926-25-000408. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reported300Share repurchases, Q1 FY2025, three months to 2025-03-31$300.0k. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-05-13, accession 0001753926-26-000845.Report this figure0.0Share repurchases, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-08-14, accession 0001753926-26-001508. Derived: 6-month figure less the 3-month figure.Report this figure0.0Share repurchases, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-12, accession 0001753926-25-001745. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-03-04, accession 0001753926-26-000435. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported

Shares

Diluted shares (weighted)16.46m, Q2 FY2026
Sensus Healthcare, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares16.6Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3016,595,029 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-13, accession 0001213900-23-086237.Report this figure16.2Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3116,245,343 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-10, accession 0001213900-24-041605.Report this figure16.2Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3016,249,766 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-13, accession 0001213900-24-068165.Report this figure16.3Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3016,270,403 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-14, accession 0001213900-24-098193.Report this figure16.3Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3116,318,047 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-15, accession 0001753926-25-000853.Report this figure16.3Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3016,333,481 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-12, accession 0001753926-25-001290.Report this figure16.3Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3016,345,749 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001753926-25-001745.Report this figure16.3Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3116,341,867 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001753926-26-000845.Report this figure16.3Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3016,320,036 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-14, accession 0001753926-26-001508.Report this figure16.3Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3016,320,036 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001753926-25-001745.Report this figure16.5Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3116,462,653 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001753926-26-000845.Report this figure16.5Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3016,462,059 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-14, accession 0001753926-26-001508.Report this figure

Shares outstanding: 16.46mShares outstanding, period not labelled, at 2026-08-1016,462,059 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-14, accession 0001753926-26-001508.Report this figure at Aug 10, 2026, from the cover of the 10-Q filed Aug 14, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. Listed shows no prices and gives no investment advice.